ZA933151B - Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds. - Google Patents

Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds.

Info

Publication number
ZA933151B
ZA933151B ZA933151A ZA933151A ZA933151B ZA 933151 B ZA933151 B ZA 933151B ZA 933151 A ZA933151 A ZA 933151A ZA 933151 A ZA933151 A ZA 933151A ZA 933151 B ZA933151 B ZA 933151B
Authority
ZA
South Africa
Prior art keywords
compounds
manufacturing
same
therapeutic agents
agents containing
Prior art date
Application number
ZA933151A
Other languages
English (en)
Inventor
Tsuyoshi Tomiyama
Akira Tomiyama
Takashi Yanigisawa
Naoto Ueyama
Tomoyuki Kawai
Motoharu Sonegawa
Hiromi Baba
Makoto Haketa
Original Assignee
Kotobuki Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kotobuki Seiyaku Co Ltd filed Critical Kotobuki Seiyaku Co Ltd
Publication of ZA933151B publication Critical patent/ZA933151B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA933151A 1992-05-22 1993-05-05 Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds. ZA933151B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4131142A JP2707390B2 (ja) 1992-05-22 1992-05-22 シクロヘプトイミダゾ−ル誘導体及びその製造方法並びにこれを含有する薬剤

Publications (1)

Publication Number Publication Date
ZA933151B true ZA933151B (en) 1993-12-06

Family

ID=15050986

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA933151A ZA933151B (en) 1992-05-22 1993-05-05 Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds.

Country Status (10)

Country Link
US (1) US5409947A (it)
JP (1) JP2707390B2 (it)
KR (1) KR0152299B1 (it)
BE (1) BE1006419A3 (it)
DE (1) DE4316117C2 (it)
ES (1) ES2103161B1 (it)
FR (1) FR2691461B1 (it)
GB (1) GB2267089B (it)
IT (1) IT1265077B1 (it)
ZA (1) ZA933151B (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA945190B (en) * 1993-07-30 1995-02-24 Kotobuki Seiyaku Co Ltd Carboxymethylidenecycloheptimidazole derivatives method or manufacturing the same and therapeutic agents containing these compounds
JP4316686B2 (ja) * 1994-09-05 2009-08-19 壽製薬株式会社 シクロヘプトイミダゾール誘導体
US6162922A (en) * 1998-01-30 2000-12-19 Bristol-Myers Squibb Co. Method for preparing N-substituted heterocyclic derivatives using a phase-transfer catalyst
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
JP4018816B2 (ja) * 1998-09-08 2007-12-05 壽製薬株式会社 シクロヘプテノン誘導体及びその製造方法並びにそれを利用してシクロヘプトイミダゾール誘導体を製造する方法
JP2004501863A (ja) * 2000-01-19 2004-01-22 アルテオン　インコーポレーテッド チアゾール、イミダゾールおよびオキサゾール化合物、ならびにタンパク質老化関連疾患の治療
WO2005039639A2 (en) * 2003-10-10 2005-05-06 Solvay Pharmaceuticals Gmbh Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker
JP4675586B2 (ja) * 2004-06-23 2011-04-27 壽製薬株式会社 高血圧症及び血清高尿酸血症の重複発症の治療のための薬剤
WO2006004030A1 (ja) * 2004-07-02 2006-01-12 Sankyo Company, Limited 組織因子産生抑制剤
KR101021828B1 (ko) 2004-10-27 2011-03-17 다이이찌 산쿄 가부시키가이샤 2 이상의 치환기를 갖는 벤젠 화합물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250554A (en) * 1989-10-24 1993-10-05 Takeda Chemical Industries, Ltd. Benzimidazole derivatives useful as angiotensin II inhibitors
US5104891A (en) * 1989-12-11 1992-04-14 G. D. Searle & Co. Cycloheptimidazolone compounds as angiotensin ii antagonists for control of hypertension

Also Published As

Publication number Publication date
GB9310492D0 (en) 1993-07-07
DE4316117A1 (de) 1993-11-25
ITMI931019A0 (it) 1993-05-18
KR940005615A (ko) 1994-03-21
JPH05320139A (ja) 1993-12-03
FR2691461A1 (fr) 1993-11-26
GB2267089A (en) 1993-11-24
DE4316117C2 (de) 2002-06-27
KR0152299B1 (ko) 1998-10-15
GB2267089B (en) 1995-10-04
BE1006419A3 (fr) 1994-08-23
ES2103161A1 (es) 1997-08-16
FR2691461B1 (fr) 1994-11-10
ES2103161B1 (es) 1998-04-01
IT1265077B1 (it) 1996-10-30
ITMI931019A1 (it) 1994-11-18
JP2707390B2 (ja) 1998-01-28
US5409947A (en) 1995-04-25

Similar Documents

Publication Publication Date Title
EP0576178A3 (en) Method for maintaining the relationships between elements.
HU9202172D0 (en) New n-benzoyl-amino-acid derivatives, medical preparatives containing said compounds and method for producing them
GR3030794T3 (en) Substituted thiazolidinedione derivatives.
GR3025363T3 (en) Medicaments.
ZA934603B (en) thiazolylvinylphenyl derivatives.
AP9300478A0 (en) 1,5 benzodiazepine derivatives
PL299260A1 (en) Biphenyl derivatives, therapeutic agents containing them and method of obtaining the sames
EP0671911A4 (en) CARBOXY-PEPTIDYL DERIVATIVES FOR USE AS ACTIVE ANTI-DEGENERATIVE AGENTS.
EP0656791A4 (en) THERAPEUTIC COMPOSITIONS AND METHODS BASED ON 2,7,9-TRICARBOXY-PYRROLOQUINOLEINE (PQQ).
PL322802A1 (en) Derivatives of 10,13,15-trioxatricyclo[9.2.1.1]-pentadecanone, method of obtaining them and therapeutic agents containing such compounds
ZA933151B (en) Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds.
EP0630383A4 (en) METHODS OF TREATING DIABETES.
EP0674707A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF LEUCOMA.
GR3021203T3 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane.
EP0592903A3 (en) Use of Ancrod in the manufacture of medications for the treatment of restenosis.
EP0597329A3 (de) Verfahren zur Herstellung von alpha-Fluor -beta-dicarbonylverbindungen.
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
GR3019015T3 (en) Process for the preparation of 1,1,1,2-tetra-fluoroethane.
GB2344586B (en) Isoquinuclidine derivatives,method of manufacturing the same and therapeutic agents for hypercholesterolemia containing these compounds
EP0557949A3 (en) Process for the preparation of 2,4,5 trifluorobenzonitrile
EP0584795A3 (en) Electronic development agent and its manufacturing process.
EP0618222A3 (en) Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid.
AU3737289A (en) Agent for treating pancreatitis or the like
GB2318789B (en) Carboxylic acid derivatives,method of manufacturing the same and therapeutic agents containing these compounds
GB2280438B (en) Carboxymethylidenecycloheptimidazole derivatives,method of manufacturing the same and therapeutic agents containing these compounds